Anhui Wanbang Pharmaceutical Technology Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -57.28% vs -21.27% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -102.54% vs -60.27% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "30.20",
          "val2": "70.70",
          "chgp": "-57.28%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-9.90",
          "val2": "8.30",
          "chgp": "-219.28%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "6.00",
          "val2": "5.50",
          "chgp": "9.09%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.30",
          "val2": "11.80",
          "chgp": "-102.54%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-328.10%",
          "val2": "46.80%",
          "chgp": "-37.49%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -27.42% vs 10.83% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -57.43% vs -20.91% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "274.00",
          "val2": "377.50",
          "chgp": "-27.42%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "20.30",
          "val2": "68.80",
          "chgp": "-70.49%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "19.00",
          "val2": "7.00",
          "chgp": "171.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "36.40",
          "val2": "85.50",
          "chgp": "-57.43%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "3.30%",
          "val2": "133.00%",
          "chgp": "-12.97%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

30.20

70.70

-57.28%

Operating Profit (PBDIT) excl Other Income

-9.90

8.30

-219.28%

Interest

0.00

0.00

Exceptional Items

6.00

5.50

9.09%

Consolidate Net Profit

-0.30

11.80

-102.54%

Operating Profit Margin (Excl OI)

-328.10%

46.80%

-37.49%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is -57.28% vs -21.27% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is -102.54% vs -60.27% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

274.00

377.50

-27.42%

Operating Profit (PBDIT) excl Other Income

20.30

68.80

-70.49%

Interest

0.00

0.00

Exceptional Items

19.00

7.00

171.43%

Consolidate Net Profit

36.40

85.50

-57.43%

Operating Profit Margin (Excl OI)

3.30%

133.00%

-12.97%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -27.42% vs 10.83% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -57.43% vs -20.91% in Dec 2024

All Annual Results